Pharmadule

Pharmadule is a Swedish pharmaceutical engineering company associated with the design, fabrication, installation and commissioning of modular manufacturing facilities. Its core concept was to apply an approach similar to modular construction in housing to pharmaceutical production plants, allowing substantial portions of a facility to be engineered and assembled away from the final site before delivery and installation. The concept was developed by founder Clas Wallenborg in 1986 after difficult overseas facility-construction projects undertaken in connection with Pharmacia. The company's business developed around turnkey and semi-turnkey solutions for regulated production environments. Its scope has included process design and engineering, facility design and engineering, fabrication of modular units, process installation, project management, commissioning, qualification, validation and regulatory support. Pharmadule has also supplied process equipment and skid-based systems for pharmaceutical, biotechnology and consumer-goods applications. This combination of engineering, manufacturing and compliance-related services positioned the company as a specialist contractor rather than a conventional drug manufacturer or consumer healthcare brand. A major organizational turning point came in July 2001, when Pharmadule AB formally merged with Emtunga International AB. The companies had maintained a close relationship for approximately fifteen years, with Emtunga serving as Pharmadule's exclusive manufacturer of modular pharmaceutical plants. The combined business became Pharmadule Emtunga AB. In the same year, Flexenclosure was separated into an independent division and subsequently operated as a standalone company with headquarters in Stockholm and a corporate hub in Vara. In December 2003, investment firm 3i acquired Pharmadule Emtunga from IDI. At that point, the business was reported to have approximately 600 employees and operations in Emtunga, Vara, Gothenburg and Stockholm. Pharmadule later expanded its manufacturing footprint through Pharmadule OÜ, established in Estonia in 2005 as a manufacturing unit delivering modular solutions, skids, equipment and orbital-welding services. Since 2011, Pharmadule Morimatsu has been owned by Morimatsu Group. The Pharmadule name therefore represents both the historical Swedish modular-pharmaceutical engineering business and a later corporate identity connected with Morimatsu's industrial and process-engineering activities. Public reference material does not provide enough information to establish the company's current legal structure, workforce, headquarters, product portfolio by model, or present operating status with precision. It is best understood as a specialist B2B engineering and construction brand serving highly regulated manufacturing environments.

Pharmadule originated in Sweden in 1986, when Clas Wallenborg developed the idea of constructing pharmaceutical production facilities in modular form. The concept followed difficult facility-construction assignments abroad for Pharmacia. Rather than building every element at the final location, the proposed method allowed major facility sections and technical systems to be designed, fabricated and prepared in controlled manufacturing environments before being transported to the project site. This approach was intended to make complex pharmaceutical construction more manageable and repeatable while supporting the quality and documentation demands of regulated production. The business established a long-running relationship with Emtunga International AB. Emtunga served as Pharmadule's exclusive manufacturer of modular pharmaceutical plants for roughly fifteen years. That relationship culminated in July 2001, when Pharmadule AB and Emtunga International AB officially merged. The resulting company was named Pharmadule Emtunga AB. The merger formalized an industrial partnership that had already integrated much of the companies' work in modular pharmaceutical-facility delivery. Also in 2001, Flexenclosure was made a separate division of Pharmadule Emtunga. It later became a standalone company, with headquarters in Stockholm and a corporate hub in Vara. This separation reflected the development of activities outside Pharmadule's central pharmaceutical-facility business. In December 2003, 3i acquired Pharmadule Emtunga from IDI. Contemporary reference material described a business with approximately 600 employees and operations in Emtunga, Vara, Gothenburg and Stockholm. The acquisition marked a change in ownership during a period when the company was established as a substantial specialist engineering and manufacturing organization rather than a small design consultancy. Pharmadule's manufacturing network also included Pharmadule OÜ, established in Estonia in 2005. The unit supplied modular solutions, skids, equipment and orbital-welding services. These capabilities complemented the company's broader project scope, which included process and facility engineering, fabrication, process installation, project management, commissioning, qualification, validation, regulatory services and process equipment. The company subsequently operated under the Pharmadule Morimatsu name and has been owned by Morimatsu Group since 2011. In this phase, the brand remained associated with complete modular-facility solutions for pharmaceutical, biotechnology and consumer-goods applications. Available public material does not document all later projects, leadership appointments, financial results or the precise current legal status of every Pharmadule-related entity. The historical record nevertheless establishes Pharmadule as a Swedish pioneer and specialist in modular pharmaceutical manufacturing infrastructure.

• 2011

  Morimatsu Group ownership

  [1]Pharmaduleen.wikipedia.org

  Pharmadule Morimatsu became owned by Morimatsu Group.

• 2005

  Pharmadule OÜ established

  [1]Pharmaduleen.wikipedia.org

  An Estonian manufacturing unit was established to deliver modular solutions, skids, equipment and orbital-welding services.

• 2003

  3i acquisition

  [1]Pharmaduleen.wikipedia.org

  3i acquired Pharmadule Emtunga from IDI.

• 2001

  Pharmadule merges with Emtunga International

  [1]Pharmaduleen.wikipedia.org

  The long-standing cooperation between Pharmadule and its exclusive modular-plant manufacturer was formalized through a merger creating Pharmadule Emtunga AB.

• 2001

  Flexenclosure becomes a separate division

  [1]Pharmaduleen.wikipedia.org

  Flexenclosure was separated from Pharmadule Emtunga and later became an independent company.

• 1986

  Modular pharmaceutical-facility concept developed

  [1]Pharmaduleen.wikipedia.org

  Clas Wallenborg developed Pharmadule's modular construction concept after difficult overseas facility projects connected with Pharmacia.

A specialist B2B engineering partner that reduces the complexity of pharmaceutical and biotechnology facility construction through modular prefabrication, integrated project delivery and regulatory-support services.

• Pharmaceutical infrastructure · 1986

  Modular pharmaceutical manufacturing facilities

  Pharmadule's central offering is the design and construction of modular facilities for pharmaceutical manufacturing. The model combines facility engineering, process engineering, prefabrication and site installation, enabling substantial parts of a plant to be produced before final assembly. The facilities are intended for regulated production settings and can include integrated process systems, utilities and documentation needed for commissioning, qualification and validation.

• Process equipment

  Process skids and equipment

  The Pharmadule business supplies process equipment and skid-based systems as part of modular facility projects. These prefabricated assemblies support the integration of production processes into a larger plant and can be manufactured, tested or prepared before delivery to the installation site. Public reference material does not identify specific equipment models or standardized product families.

• Manufacturing service · 2005

  Orbital-welding services

  Pharmadule OÜ is described as providing orbital-welding services alongside modular solutions, skids and equipment. The service supports the fabrication of process piping and other precision assemblies used in regulated industrial environments. No detailed technical specifications or current service availability are established in the supplied sources.

• 2011

  Ownership by Morimatsu GroupM&A

  Background

  The Pharmadule business continued to be associated with modular facilities, engineering services and process equipment for pharmaceutical and related industries.

  Action taken

  Pharmadule Morimatsu became owned by Morimatsu Group.

  Aftermath

  The brand became part of Morimatsu Group's broader industrial ownership structure. The supplied sources do not specify transaction terms or subsequent organizational changes.

  Source

• 2003

  Sale of Pharmadule Emtunga to 3iM&A

  Background

  Pharmadule Emtunga operated as a specialist modular-facility engineering and manufacturing company with activities in several Swedish locations.

  Action taken

  3i acquired Pharmadule Emtunga from IDI in December 2003.

  Aftermath

  The transaction transferred ownership to an investment firm. The company was reported to have approximately 600 employees at the time.

  Source

• 2001

  Merger with Emtunga International ABM&A

  Background

  Pharmadule and Emtunga had worked closely for approximately fifteen years, with Emtunga acting as Pharmadule's exclusive manufacturer of modular pharmaceutical plants.

  Action taken

  The two companies formally merged in July 2001 to create Pharmadule Emtunga AB.

  Aftermath

  The merger consolidated the design and manufacturing relationship behind Pharmadule's modular-facility business. Flexenclosure was separated as a distinct division during the same year.

  Source

1. 1Pharmaduleen.wikipedia.org